Non-alcoholic fatty liver disease MRI: Difference between revisions
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
MRI is helpful in the diagnosis of NAFLD. An MRI is one of the best tools in imaging modalities available to diagnose NAFLD. An MRI is simple to test which allows quantification of the hepatic steatosis. MRI has a sensitivity of 96% and specificity of 93% in diagnosing NAFLD. However, it uses is limited because of the cost. | [[Magnetic resonance imaging|MRI]] is helpful in the diagnosis of NAFLD. An [[Magnetic resonance imaging|MRI]] is one of the best tools in imaging modalities available to diagnose NAFLD. An MRI is simple to test which allows [[quantification]] of the [[hepatic steatosis]]. MRI has a [[Sensitivity (tests)|sensitivity]] of 96% and [[specificity]] of 93% in diagnosing NAFLD. However, it uses is limited because of the cost. | ||
==MRI== | ==MRI== | ||
*Abdominal MRI may be helpful in the diagnosis of NAFLD. Findings on MRI suggestive NAFLD include:<ref name="urlNonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician">{{cite web |url=http://www.aafp.org/afp/2013/0701/p35.html#afp20130701p35-b13 |title=Nonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician |format= |work= |accessdate=}}</ref> | *[[Abdominal]] [[MRI]] may be helpful in the diagnosis of NAFLD. Findings on [[MRI]] suggestive NAFLD include:<ref name="urlNonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician">{{cite web |url=http://www.aafp.org/afp/2013/0701/p35.html#afp20130701p35-b13 |title=Nonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician |format= |work= |accessdate=}}</ref><ref name="urlNonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician2">{{cite web |url=http://www.aafp.org/afp/2013/0701/p35.html |title=Nonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician |format= |work= |accessdate=}}</ref> | ||
*MRI helps in especially for longitudinal follow-up of patients with NAFLD. | *MRI helps in especially for longitudinal follow-up of patients with NAFLD. | ||
**Quantification of hepatic steatosis.<ref name="pmid24040614">{{cite journal |vauthors=Ligabue G, Besutti G, Scaglioni R, Stentarelli C, Guaraldi G |title=MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends |journal=Quant Imaging Med Surg |volume=3 |issue=4 |pages=192–5 |year=2013 |pmid=24040614 |pmc=3759141 |doi=10.3978/j.issn.2223-4292.2013.08.01 |url=}}</ref> | **[[Quantification]] of [[hepatic steatosis]].<ref name="pmid24040614">{{cite journal |vauthors=Ligabue G, Besutti G, Scaglioni R, Stentarelli C, Guaraldi G |title=MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends |journal=Quant Imaging Med Surg |volume=3 |issue=4 |pages=192–5 |year=2013 |pmid=24040614 |pmc=3759141 |doi=10.3978/j.issn.2223-4292.2013.08.01 |url=}}</ref>.<ref name="pmid24966609">{{cite journal |vauthors=Lee SS, Park SH |title=Radiologic evaluation of nonalcoholic fatty liver disease |journal=World J. Gastroenterol. |volume=20 |issue=23 |pages=7392–402 |year=2014 |pmid=24966609 |pmc=4064084 |doi=10.3748/wjg.v20.i23.7392 |url=}}</ref> | ||
*Another kind of MRI is magnetic resonance spectroscopy (MRS) which reflects fat in the whole liver like [[Triglyceride|triglycerides]] in a specific volume; and [[proton]] density fat fraction (PDFF) .<ref name="pmid288000872">{{cite journal |vauthors=Di Martino M, Koryukova K, Bezzi M, Catalano C |title=Imaging Features of Non-Alcoholic Fatty Liver Disease in Children and Adolescents |journal=Children (Basel) |volume=4 |issue=8 |pages= |year=2017 |pmid=28800087 |pmc=5575595 |doi=10.3390/children4080073 |url=}}</ref> | |||
*Another kind of MRI is magnetic resonance spectroscopy (MRS) which reflects fat in the whole liver like triglycerides in a specific volume; and proton density fat fraction (PDFF) .<ref name="pmid288000872">{{cite journal |vauthors=Di Martino M, Koryukova K, Bezzi M, Catalano C |title=Imaging Features of Non-Alcoholic Fatty Liver Disease in Children and Adolescents |journal=Children (Basel) |volume=4 |issue=8 |pages= |year=2017 |pmid=28800087 |pmc=5575595 |doi=10.3390/children4080073 |url=}}</ref> | |||
==References== | ==References== |
Revision as of 03:48, 18 December 2017
Non-Alcoholic Fatty Liver Disease Microchapters |
Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases |
---|
Diagnosis |
Treatment |
Case studies |
Non-alcoholic fatty liver disease MRI On the Web |
American Roentgen Ray Society Images of Non-alcoholic fatty liver disease MRI |
Directions to Hospitals Treating Non-alcoholic fatty liver disease |
Risk calculators and risk factors for Non-alcoholic fatty liver disease MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
MRI is helpful in the diagnosis of NAFLD. An MRI is one of the best tools in imaging modalities available to diagnose NAFLD. An MRI is simple to test which allows quantification of the hepatic steatosis. MRI has a sensitivity of 96% and specificity of 93% in diagnosing NAFLD. However, it uses is limited because of the cost.
MRI
- Abdominal MRI may be helpful in the diagnosis of NAFLD. Findings on MRI suggestive NAFLD include:[1][2]
- MRI helps in especially for longitudinal follow-up of patients with NAFLD.
- Another kind of MRI is magnetic resonance spectroscopy (MRS) which reflects fat in the whole liver like triglycerides in a specific volume; and proton density fat fraction (PDFF) .[5]
References
- ↑ "Nonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician".
- ↑ "Nonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician".
- ↑ Ligabue G, Besutti G, Scaglioni R, Stentarelli C, Guaraldi G (2013). "MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends". Quant Imaging Med Surg. 3 (4): 192–5. doi:10.3978/j.issn.2223-4292.2013.08.01. PMC 3759141. PMID 24040614.
- ↑ Lee SS, Park SH (2014). "Radiologic evaluation of nonalcoholic fatty liver disease". World J. Gastroenterol. 20 (23): 7392–402. doi:10.3748/wjg.v20.i23.7392. PMC 4064084. PMID 24966609.
- ↑ Di Martino M, Koryukova K, Bezzi M, Catalano C (2017). "Imaging Features of Non-Alcoholic Fatty Liver Disease in Children and Adolescents". Children (Basel). 4 (8). doi:10.3390/children4080073. PMC 5575595. PMID 28800087.